EISAI INC FDA Approval NDA 021911

NDA 021911

EISAI INC

FDA Drug Application

Application #021911

Documents

Letter2009-11-24
Letter2011-03-08
Letter2015-02-17
Label2010-11-08
Label2011-03-07
Label2015-07-01
Letter2008-11-18
Letter2010-11-10
Letter2011-06-03
Letter2015-06-26
Label2008-11-17
Label2015-03-03
Review2009-02-19
Summary Review2009-02-19
Pediatric Written Request2015-01-13
Pediatric Amendment 12015-01-13
Letter2019-11-29
Label2019-12-02
Medication Guide2019-11-29

Application Sponsors

NDA 021911EISAI INC

Marketing Status

Discontinued001
Prescription002
Prescription003

Application Products

001TABLET;ORAL100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1BANZELRUFINAMIDE
002TABLET;ORAL200MG1BANZELRUFINAMIDE
003TABLET;ORAL400MG1BANZELRUFINAMIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2008-11-14STANDARD
LABELING; LabelingSUPPL4AP2009-10-16STANDARD
LABELING; LabelingSUPPL5AP2010-11-08STANDARD
REMS; REMSSUPPL7AP2011-03-03N/A
REMS; REMSSUPPL8AP2011-06-10N/A
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2013-06-06STANDARD
LABELING; LabelingSUPPL12AP2015-02-12STANDARD
LABELING; LabelingSUPPL13AP2015-06-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2016-06-17STANDARD
LABELING; LabelingSUPPL17AP2019-11-28STANDARD

Submissions Property Types

ORIG1Null7
SUPPL4Null7
SUPPL5Null6
SUPPL7Null7
SUPPL8Null6
SUPPL10Null0
SUPPL12Null8
SUPPL13Null15
SUPPL14Null0
SUPPL17Null7

TE Codes

002PrescriptionAB
003PrescriptionAB

CDER Filings

EISAI INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21911
            [companyName] => EISAI INC
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/021911s017,201367s008lbl.pdf#page=19"]
            [products] => [{"drugName":"BANZEL","activeIngredients":"RUFINAMIDE","strength":"100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"BANZEL","activeIngredients":"RUFINAMIDE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"BANZEL","activeIngredients":"RUFINAMIDE","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"11\/28\/2019","submission":"SUPPL-17","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/021911s017,201367s008lbl.pdf\"}]","notes":""},{"actionDate":"06\/25\/2015","submission":"SUPPL-13","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"06\/25\/2015","submission":"SUPPL-13","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"06\/25\/2015","submission":"SUPPL-13","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"02\/12\/2015","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/021911s012lbl.pdf\"}]","notes":""},{"actionDate":"03\/03\/2011","submission":"SUPPL-7","supplementCategories":"REMS-Modified","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/0201367,021911s007lbl.pdf\"}]","notes":""},{"actionDate":"11\/08\/2010","submission":"SUPPL-5","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/021911s005lbl.pdf\"}]","notes":""},{"actionDate":"11\/14\/2008","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/021911lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"BANZEL","submission":"RUFINAMIDE","actionType":"100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"BANZEL","submission":"RUFINAMIDE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"BANZEL","submission":"RUFINAMIDE","actionType":"400MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-11-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.